Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Medicine, Multiple sclerosis, Magnetic resonance imaging, Atrophy, Neurology, and Disease.
2024 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease
Epilepsy in MS and its association with cognitive and psychological burden
Brain bright spotty lesions and leukodystrophy-like patterns in NMOSD relapse
Perioperative Predictors of Recurrency in Chronic Subdural Hematoma: A Retrospective Analysis of 150 Consecutive Cases
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials
Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report
Cortical plasticity in AQP4-positive NMOSD: a transcranial magnetic stimulation study
Neurophysiological methods for assessing and treating cognitive impairment in multiple sclerosis: A scoping review of the literature
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT)
Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literature
Correction to: Concurrent management of multiple sclerosis and natalizumab‑induced hepatitis with ofatumumab: a case report
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
Multiple Sclerosis Progression and Relapse Activity in Children
Prognostic value of single-subject grey matter networks in early multiple sclerosis
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis
Cortical remyelination failure predicts cortical atrophy and clinical progression in early multiple sclerosis (P2-4.008)
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age Paradigm